Avricore Health (AVCRF) Gross Margin (2009 - 2026)
Avricore Health (AVCRF) posted quarterly Gross Margin of 19.36% for Q2 2026, up 14826.0% year-over-year from N/an in Q2 2025, and up 11.36% quarter-over-quarter from 21.84% in Q4 2025.
Avricore Health (AVCRF) Gross Margin (2009 - 2026) Analysis & Trends
Avricore Health (AVCRF) has reported Gross Margin for 16 consecutive years, with 19.36% the latest figure, recorded in Q2 2026.
- In Q2 2026, Gross Margin rose 14826.0% year-over-year to 19.36%; the TTM figure through Jun 2026 stood at 81.04% (down 12167.0% YoY), while the FY2025 annual figure was 44.63%, up 534.0% from the prior year.
- Gross Margin advanced to 19.36% in Q2 2026 per AVCRF's latest filing, from 21.84% in the prior quarter.
- Across five years, Gross Margin topped out at 79.78% in Q1 2025 and bottomed at 167.63% in Q2 2025.
- Historically, Gross Margin has averaged 6.3% across 5 years, with a median of 32.88% in 2022.
- Annual changes were most pronounced in 2025 — Gross Margin sank 20706 bps — and 2026, when it soared 14826 bps.
- Avricore Health's Gross Margin stood at 17.28% in 2022, then jumped by 114 bps to 37.02% in 2023, then advanced by 4 bps to 38.35% in 2024, then sank by 157 bps to 21.84% in 2025, then gained by 11 bps to 19.36% in 2026.
- Business Quant data shows AVCRF's Gross Margin at 19.36% in Q2 2026, 21.84% in Q4 2025, and 139.6% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 69.57% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 57.64% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 64.04% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 53.95% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 32.85% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 99.91% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 66.44% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 63.29% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 33.75% |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 | -19.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19.36% |
| Dec 31, 2025 | -21.84% |
| Sep 30, 2025 | -139.60% |
| Jun 30, 2025 | -167.63% |
| Mar 31, 2025 | 79.78% |
| Sep 30, 2024 | 38.35% |
| Jun 30, 2024 | 39.44% |
| Mar 31, 2024 | 43.12% |
| Dec 31, 2023 | 37.02% |
| Sep 30, 2023 | 27.46% |
| Jun 30, 2023 | 41.87% |
| Mar 31, 2023 | 33.48% |
| Dec 31, 2022 | 17.28% |
| Sep 30, 2022 | 37.74% |
| Jun 30, 2022 | 32.28% |
| Mar 31, 2022 | 21.38% |
| Dec 31, 2021 | 26.48% |
| Sep 30, 2021 | 27.37% |
| Jun 30, 2021 | -20.21% |
| Mar 31, 2021 | 21.74% |